THE LUSTGARTEN FOUNDATION FOR PANCREATIC CANCER RESEARCH EXPRESSES CONDOLENCES FOR THE LOSS OF SALLY RIDE
BETHPAGE, NY, July 24, 2012 – The Lustgarten Foundation, the nation’s largest private foundation dedicated solely to funding pancreatic cancer research, today offered the following statement concerning the death of Sally Ride, the country’s first female astronaut and space pioneer:
Kerri Kaplan, Lustgarten Foundation Executive Director, said: "The Lustgarten Foundation would like to express its condolences to the family and friends of Sally Ride, who died after a courageous battle with pancreatic cancer. She was an inspiration to many and we commend her pioneering spirit and her commitment to advancing science. For Ms. Ride and for the 44,000 others diagnosed with pancreatic cancer each year, we remain steadfast in our commitment to advance science through research to detect pancreatic cancer earlier, to develop better treatments, and ultimately, to find a cure for this lethal disease."